Pinatuzumab vedotin Antibody
Pinatuzumab vedotin (CAS 1313706-14-7) is an antibody-drug conjugate (ADC) designed for research use. It has been investigated in preclinical and clinical studies for targeting non-Hodgkin lymphoma, demonstrating activity in both in vitro and in vivo models.
Product Specifications
Target
Immunology/Inflammation related, Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog